Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
CMV Vaccine for Liver Transplant Recipients
Recruiting0 awardsPhase 2
Baltimore, Maryland
This trial will study the effects of two doses of a CMV vaccine on preventing CMV disease in liver transplant recipients, using a protocol-mandated preemptive therapy strategy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.